Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:304ce04b6adbe9be34fe9d7fb4b0b277' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>RATIONALE: Drugs used in chemotherapy, work in different ways to stop tumor cells from dividing so they stop growing or die. Steroid therapy decreases inflammation. Combining chemotherapy and steroid therapy with immunoglobulin may be effective in treating abnormal muscle movement associated with neuroblastoma. PURPOSE: This randomized phase II trial is studying cyclophosphamide, prednisone, and immunoglobulin to see how well they work compared to cyclophsophamide and prednisone alone in treating patients with abnormal trunk muscle movements associated with neuroblastoma.</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:304ce04b6adbe9be34fe9d7fb4b0b277' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:95439bd9225a8995fc640662b1783f8c' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:95439bd9225a8995fc640662b1783f8c' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:4bec4ae99330d91c1d0b6be8da989ef7' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>OBJECTIVES:\n<ul>\n<li>Determine whether cyclophosphamide and prednisone with or without immune globulin is a reasonable baseline standard therapy for pediatric patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia (OMA) syndrome.</li>\n<li>Determine whether immunosuppressive therapy with cyclophosphamide and prednisone is an effective backbone therapy for OMA upon which to build additional treatment for these patients.</li>\n<li>Determine whether these regimens improve OMA syndrome in these patients.</li>\n<li>Determine whether these regimens improve motor coordination in these patients.</li>\n<li>Determine whether these regimens improve functional outcome in these patients.</li>\n<li>Compare the event-free and overall survival of patients treated with these regimens.</li>\n</ul>\n</p><p> OUTLINE: This is a randomized, multicenter study. Patients are stratified according to risk group per protocol COG-ANBL00B1 (low risk vs intermediate risk on COG-A3961 vs high risk on COG-A3973).\n<ul>\n<li>Chemotherapy: Patients with intermediate-risk or high-risk neuroblastoma receive chemotherapy (including cyclophosphamide) according to the standard of care for the stage of primary neuroblastoma, beginning on day 0. Patients with low-risk neuroblastoma (and not receiving other chemotherapy) receive cyclophosphamide IV over 1 hour on day 0. Treatment repeats every 4 weeks for 6 courses in the absence of disease progression or unacceptable toxicity.</li>\n</ul>\n</p><p> All patients receive prednisone twice daily for 3 months and then every other day for 7-15 months.\n<ul>\n<li>Immune globulin therapy: Patients are randomized to 1 of 2 treatment arms.\n<ul>\n<li>Arm I: Patients receive immune globulin IV on days -2 and -1, at weeks 4, 8, 12, 16, 20, and 24, and then at months 8, 10, and 12 after therapy.</li>\n</ul>\n</li>\n</ul>\n</p><p> Treatment continues in the absence of disease progression or unacceptable toxicity. Patients with no response after 6 months go off treatment.\n<ul>\n<li>Arm II: Patients do not receive immune globulin. Patients with unresponsive opsoclonus-myoclonus-ataxia syndrome after 2 months or progression after 6 months may cross over to arm I. Patients are followed during therapy every month for 6 months, at 1 year, and then annually thereafter.</li>\n</ul>\n</p><p> PROJECTED ACCRUAL: A total of 18-52 patients (9-26 per treatment arm) will be accrued for this study within 2-5.8 years.</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:4bec4ae99330d91c1d0b6be8da989ef7' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:e61c1dc27ece3714479a880aaf4387e2' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>DISEASE CHARACTERISTICS:\n<ul>\n<li>Newly diagnosed neuroblastoma with tumor-associated opsoclonus-myoclonus-ataxia syndrome\n<ul>\n<li>Must enroll on study within 4 weeks of diagnosis</li>\n<li>Presence of opsoclonus, myoclonus, and/or ataxia associated with neuroblastoma considered eligible</li>\n</ul>\n</li>\n<li>Currently enrolled on COG neuroblastoma protocols: COG-ANBL00B1 or its successor</li>\n</ul>\n</p><p> PATIENT CHARACTERISTICS: Age:\n<ul>\n<li>8 and under</li>\n</ul>\n</p><p> Performance status:\n<ul>\n<li>Not specified</li>\n</ul>\n</p><p> Life expectancy:\n<ul>\n<li>Not specified</li>\n</ul>\n</p><p> Hematopoietic:\n<ul>\n<li>Not specified</li>\n</ul>\n</p><p> Hepatic:\n<ul>\n<li>Not specified</li>\n</ul>\n</p><p> Renal:\n<ul>\n<li>Not specified</li>\n</ul>\n</p><p> PRIOR CONCURRENT THERAPY: Biologic therapy:\n<ul>\n<li>Not specified</li>\n</ul>\n</p><p> Chemotherapy:\n<ul>\n<li>No prior chemotherapy</li>\n<li>Concurrent chemotherapy allowed</li>\n</ul>\n</p><p> Endocrine therapy:\n<ul>\n<li>No prior prednisone or corticotropin</li>\n</ul>\n</p><p> Radiotherapy:\n<ul>\n<li>Not specified</li>\n</ul>\n</p><p> Surgery:\n<ul>\n<li>Concurrent surgery allowed</li>\n</ul>\n</p>', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:e61c1dc27ece3714479a880aaf4387e2' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:cd143cb4ce88cdb8149674e3ed22d993' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>Efficacy as measured by assessment of response of opsoclonus, gait, neural, stance, arm and hand function at baseline, 2 months, 6 months, and 1 year [ Designated as safety issue: No ]</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:cd143cb4ce88cdb8149674e3ed22d993' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:ee1a0e890679cee423326351c6d3ab97' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>Response as measured by assessment of opsoclonus, gait, neural, stance, arm and hand function at baseline, 2 months, 6 months, and 1 year [ Designated as safety issue: No ]</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:ee1a0e890679cee423326351c6d3ab97' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:9cb02e5bab7a8b78d75884aec1a94c2d' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>Motor coordination as assessed by neurological examination and Vineland Adaptive Behavior Scale at baseline, 1 and 5 years [ Designated as safety issue: No ]</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:9cb02e5bab7a8b78d75884aec1a94c2d' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:fef485e06d6a82dcd02f332f1e1adebf' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>Functional outcome as assessed by age-appropriate neuropsychological testing at baseline, 1 and 5 years [ Designated as safety issue: No ]</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:fef485e06d6a82dcd02f332f1e1adebf' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:505400905d462fe0af90ad91e046a3b5' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>Long-term prognosis for neurologic recovery by neurological examination at baseline, 1 and 5 years [ Designated as safety issue: No ]</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:505400905d462fe0af90ad91e046a3b5' in /persistent/html/includes/cache.inc on line 109.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:2babd49ca9f14f5761cbdfb2685e0d3d' in /persistent/html/includes/cache.inc on line 26.
- user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>Tumor outcome in terms of event-free survival and overall survival at 1, 5, and 10 years [ Designated as safety issue: No ]</p>\n', created = 1283575954, expire = 1283662354, headers = '', serialized = 0 WHERE cid = '1:2babd49ca9f14f5761cbdfb2685e0d3d' in /persistent/html/includes/cache.inc on line 109.
Trial phase:
Phase III
Recruitment status:
Recruiting RATIONALE: Drugs used in chemotherapy, work in different ways to stop tumor cells from dividing so they stop growing or die. Steroid therapy decreases inflammation. Combining chemotherapy and steroid therapy with immunoglobulin may be effective in treating abnormal muscle movement associated with neuroblastoma. PURPOSE: This randomized phase II trial is studying cyclophosphamide, prednisone, and immunoglobulin to see how well they work compared to cyclophsophamide and prednisone alone in treating patients with abnormal trunk muscle movements associated with neuroblastoma.
Conditions
Asthma
Brain and Central Nervous System Tumors
Breast Cancer
Cancer
Cardiovascular Diseases
Colorectal Cancer
Depression
Healthy
Heart Diseases
HIV Infections
Hypertension
Leukemia
Lung Cancer
Lymphoma
Myelodysplastic Syndromes
Obesity
Ovarian Cancer
Prostate Cancer
Schizophrenia
Unspecified Adult Solid Tumor, Protocol Specific
Clinical trial sponsors
AstraZeneca
Bristol-Myers Squibb
Department of Veterans Affairs
Eli Lilly and Company
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
GlaxoSmithKline
Hoffmann-La Roche
M.D. Anderson Cancer Center
Memorial Sloan-Kettering Cancer Center
Merck
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Drug Abuse (NIDA)
Novartis
Pfizer
Sanofi-Aventis
User login
Study design
Active Control
Cohort
Crossover Assignment
Dose Comparison
Double-Blind
Double Blind (Subject, Investigator)
Efficacy Study
Non-Randomized
Open Label
Other
Parallel Assignment
Placebo Control
Prevention
Prospective
Randomized
Safety/Efficacy Study
Safety Study
Single Group Assignment
Treatment
Uncontrolled
